Managing Mental Health Conditions in Primary Care Settings

Journal of Midwifery and Women's Health

Volumn 55, Issue 1, 2010, Pages 9-19

  Hackley, Barbara ^a   Sharma, Chanchal ^a   Kedzior, Angela ^a   Sreenivasan, Shared ^a  

^a NONE

Author keywords

depression; screening; treatment

Indexed keywords

AMFEBUTAMONE; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; DIPHENHYDRAMINE; DOPAMINE UPTAKE INHIBITOR; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE MALEATE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN 2 ANTAGONIST; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ZOLPIDEM TARTRATE;

AGITATION; ANXIETY; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; BLOOD PRESSURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMMUNITY CARE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DYSTHYMIA; FAMILY THERAPY; GENERALIZED ANXIETY DISORDER; GROUP THERAPY; HEADACHE; HEALTH CENTER; HUMAN; HYPERTENSIVE CRISIS; INSOMNIA; LETHARGY; LIVER TOXICITY; LOW DRUG DOSE; MAJOR DEPRESSION; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; NAUSEA; NEUROPATHIC PAIN; PANIC; PATIENT SAFETY; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTIRELIN TEST; PSYCHIATRIC DIAGNOSIS; PSYCHOEDUCATION; PSYCHOPHARMACOTHERAPY; SCREENING TEST; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SUICIDAL IDEATION; TREATMENT PLANNING; TREATMENT RESPONSE; URBAN AREA; WEIGHT GAIN; WEIGHT REDUCTION; WITHDRAWAL SYNDROME; WOMEN'S HEALTH;

ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HUMANS; MENTAL HEALTH; PATIENT CARE TEAM; PRIMARY HEALTH CARE; PSYCHOMETRICS; PSYCHOTHERAPY; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 72249087815     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmwh.2009.06.004     Document Type: Article

References (62)

1. Healthy People 2010 Web site. Mental health and mental disorders objective 18). Available from: www.healthypeople.gov/Document/HTML/Volume2/18Mental.htm [Accessed April 5, 2008].
2. Institute for Clinical Systems Improvement Web site. Health care guidelines: Major depression in adults in primary care, 12th edition. Available from: www.icsi.org/depression_5/depression__major__in_adults_in_primary_care_3.html [Accessed November 22, 2008].
3. LaRocco-Cockburn A., Melville J., Bell M., and Katon W. Depression screening attitudes and practices among obstetrician-gynecologists. Obstet Gynecol 101 5 part 1 (2003) 892-898
4. Gaynes B.N., Gavin N., Meltzer-Brody S., Lohr K.N., Swinson T., Gartlehner G., et al. Perinatal depression: Prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ) 119 (2005) 1-8
5. Agency for Healthcare Research and Quality Web site. US Preventive Services Task Force. Screening for depression. Recommendations and rationale. Rockville (MD): Agency for Healthcare Research and Quality. Available from: www.ahrq.gov/clinic/3rduspstf/depression/depressrr.htm[Accessed April 4, 2008].
6. Vesga-Lopez O., Blanco C., Deyes K., Olfson M., Grant B., and Hasin D. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 65 (2008) 805-815
7. Sharp L.K., and Lipsky M.S. Screening for depression across the lifespan: A review of measures for use in primary care settings. Am Fam Physician 66 (2002) 1001-1008
8. Arroll B., Khin N., and Kerse N. Screening for depression in primary care with two verbally asked questions: cross sectional study. BMJ 327 (2003) 1144-1146
9. Evaluation of chronic fatigue. In: Goroll A., and Mulley A. (Eds). Primary care medicine: Office evaluation and management of the adult patient (2008), Lippincott Williams & Wilkins, Philadelphia (PA) 54-60
10. Pies R., and Shader R. Approaches to the treatment of depression. In: Shader R. (Ed). Manual of psychiatric therapeutics (2003), Lippincott Williams & Wilkins, Philadelphia (PA) 240-269
11. Di Giulio G., and Reissing E.D. Premenstrual dysphoric disorder: Prevalence, diagnostic considerations, and controversies. J Psychosom Obstet Gynaecol 27 (2006) 201-210
12. Nock M., Borges G., Bromet E., Cha C., Kessler R., and Lee S. Suicide and suicidal behavior. Epidemiol Rev 30 (2008) 133-154
13. Friedman S., Hrouda D., Holden C., Noffsinger S., and Resnick P. Filicide-suicide: Common factors in parents who kill their children and themselves. J Am Acad Psychiatry Law 33 (2005) 496-504
14. Borget D., Grace J., and Whitehurst L. A review of maternal and patenal filicide. J Am Acad Psychiatry Law 35 (2007) 74-82
15. The MacArthur Initiative on Depression & Primary Care at Dartmouth & Duke, Depression Management Toolkit, 2004. Available from: www.depression-primarycare.org/clinicians/toolkits/full/ [Accessed April 4, 2008].
16. Otto M.W., Smits J.A.J., and Reese H.E. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clin Psychol (New York) 12 (2005) 72-86
17. Segal Z., Vincent P., and Levitt A. Efficacy of combined, sequential, and crossover psychotherapy and pharmacotherapy in improving outcomes in depression. J Psychiatry Neurosci 27 (2002) 281-290
18. DeRubeis R., Hollon S., Amsterdam J., Shelton R., Young P., Salomon R., et al. Cognitive therapy vs. medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 62 (2005) 409-416
19. Pampallona S., Bollini P., Tibaldi G., Kupelnick B., and Munizza C. Combined pharmacotherapy and psychological treatment for depression: A systematic review. Arch Gen Psychiatry 61 (2004) 714-719
20. Hollon S.D., DeRubeis R.J., Shelton R.C., Amsterdam J.D., Salomon R.M., O'Reardon J.P., et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 62 (2005) 417-422
21. Vittengl J.R., Clark L.A., Dunn T.W., and Jarrett R.B. Reducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol 75 (2007) 475-488
22. Hollon S.D., Stewart M.O., and Strunk D. Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety. Annu Rev Psychol 57 (2006) 285-315
23. Paykel E.S. Cognitive therapy in relapse prevention in depression. Int J Neuropsychopharmacol 10 (2007) 131-136
24. Bockting C.L., Schene A.H., Spinhoven P., Koeter M.W., Wouters L.F., Huyser J., et al. Preventing relapse/recurrence in recurrent depression with cognitive therapy: A randomized controlled trial. J Consult Clin Psychol 73 (2005) 647-657
25. Leykin Y., Amsterdam J.D., DeRubeis R.J., Gallop R., Shelton R.C., and Hollon S.D. Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. J Consult Clin Psychol 75 (2007) 267-276
26. Fava G., and Ruini C. What is the optimal treatment of mood and anxiety disorders?. Clin Psychol (New York) 12 (2005) 92-96
27. Frank E., Grochocinski V.J., Spanier C.A., Buysse D.J., Cherry C.R., Houck P.R., et al. Interpersonal psychotherapy and antidepressant medication: Evaluation of a sequential treatment strategy in women with recurrent major depression. J Clin Psychiatry 61 (2006) 51-57
28. Office of Women's Health. Achieving remission in depression: Managing women and men in the primary care setting. Clinical Courier 2003. Available from: http://www.4women.gov/healthpro/edu/clinical_Courier_8.PDF [Accessed May 30, 2008].
29. Anderson I.M. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability. J Affect Disord 58 (2000) 19-36
30. Rapaport M.H. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: The state of the art. J Clin Psychiatry 68 suppl 8 (2007) 42-46
31. Henry J.A., Alexander C.A., and Sener E.K. Relative mortality from overdose of antidepressants. BMJ 310 (1995) 221-224
32. Cheeta S., Schifano F., Oyefeso A., Webb L., and Ghodse A.H. Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000. Br J Psychiatry 184 (2004) 41-47
33. Mendelson W.B. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry 66 (2005) 469-476
34. DeSanty K.P., and Amabile C.M. Antidepressant-induced liver injury. Ann Pharmacother 41 (2007) 1201-1211
35. Garrison G.D., and Levin G.M. Factors affecting prescribing of the newer antidepressants. Ann Pharmacother 34 (2000) 10-14
36. Dording C.M., Mischoulon D., Petersen T.J., Kornbluh R., Gordon J., Nierenberg A.A., et al. The pharmacologic management of SSRI-induced side effects: A survey of psychiatrists. Ann Clin Psychiatry 14 (2002) 143-147
37. Perugi G., Frare F., Toni C., Ruffolo G., and Torti C. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: Effectiveness, tolerability and predictors of response. Neuropsychobiology 46 (2002) 145-149
38. Fava M., Rosenbaum J., Hoog S., Tepner R., Kopp J., and Nilsson M. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. J Affect Disord 59 (2000) 119-126
39. Carrasco J.L., Díaz-Marsá M., and Sáiz-Ruiz J. Sertraline in the treatment of mixed anxiety and depression disorder. J Affect Disord 59 (2000) 67-69
40. Fava M., Hoog S.L., Judge R.A., Kopp J.B., Nilsson M.E., and Gonzales J.S. Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia. J Clin Psychopharmacol 22 (2002) 137-147
41. Ferguson J.M. SSRI antidepressant medications: Adverse effects and tolerability. Prim Care Companion J Clin Psychiatry 3 (2001) 22-27
42. Ditto K.E. SSRI discontinuation syndrome. Awareness as an approach to prevention. Postgrad Med 114 (2003) 79-84
43. Deshmukh R., and Franco K. Managing weight gain as a side effect of antidepressant therapy. Cleve Clin J Med 70 (2003) 614 616, 618, passim
44. Mann J.J. The medical management of depression. N Engl J Med 353 (2005) 1819-1834
45. Clayton A.H., Croft H.A., Horrigan J.P., Wightman D.S., Krishen A., Richard N.E., et al. Bupropion extended release compared with escitalopram: Effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 67 (2006) 736-746
46. Fava M., Judge R., Hoog S.L., Nilsson M.E., and Koke S.C. Fluoxetine versus sertraline and paroxetine in major depressive disorder: Changes in weight with long-term treatment. J Clin Psychiatry 61 (2000) 863-867
47. Krupnick J.L., Sotsky S.M., Simmens S., Moyer J., Elkin I., Watkins J., et al. The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol 64 (1996) 532-553
48. Muñoz R.F., Ying Y.W., Bernal G., Pérez-Stable E.J., Sorensen J.L., Hargreaves W.A., et al. Prevention of depression with primary care patients: A randomized controlled trial. Am J Community Psychol 23 (1993) 199-222
49. Peden A.R., Hall L.A., Rayens M.K., and Beebe L.L. Reducing negative thinking and depressive symptoms in college women. J Nurs Scholarsh 32 (2000) 145-151
50. Peden A.R., Rayens M.K., Hall L.A., and Beebe L.H. Preventing depression in high-risk college women: A report of an 18-month follow-up. J Am Coll Health 49 (2001) 299-306
51. Butler A.C., Chapman J.E., Forman E.M., and Beck A.T. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clin Psychol Rev 26 (2006) 17-31
52. Wolf N.J., and Hopko D.R. Psychosocial and pharmacological interventions for depressed adults in primary care: A critical review. Clin Psychol Rev 28 (2008) 131-161
53. Mynors-Wallis L.M., Gath D.H., Day A., and Baker F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment of major depression in primary care. BMJ 320 (2000) 26-30
54. Huibers M.J., Beurskens A.J., Bleijenberg G., and van Schayck C.P. The effectiveness of psychosocial interventions delivered by general practitioners. Cochrane Database Syst Rev 2 (2003) CD003494
55. New York City Department of Health Web site. Take care Hunts Point and Mott Haven. Community health profiles, 2nd edition. Available at: www.nyc.gov/html/doh/downloads/pdf/data/2006chp-107.pdf [Accessed November 22, 2008].
56. Dejesus R.S., Vickers K.S., Melin G.J., and Williams M.D. A system-based approach to depression management in primary care using the Patient Health Questionnaire-9. Mayo Clin Proc 82 (2007) 1395-1402
57. Agency for Healthcare Research and Quality Web site. US Preventive Services Task Force. Screening thyroid disease: Recommendation statement (2004), Agency for Healthcare Research and Quality, Rockville (MD)
58. Clayton A., Kornstein S., Prakash A., Mallinckrodt C., and Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 4 4 part 1 (2007) 917-929
59. Potter W., and Hollister L. Antidepressant agents. In: Katzung B. (Ed). Basic & clinical pharmacology. 10th edition (2007), McGraw Hill, New York
60. Micromedex healthcare series. Bupropion hydrochloride. Available from: www.thomsonhc.com/hcs/librarian/ND_T/HCS/ND_PR/Main/CS/44E670/DUPLICATIONSHIELDSYNC/2CE577/ND_PG/PRIH/ND_B/HCS/SBK/1/ND_P/Main/PFPUI/n716h3m2IAWt9d/PFActionId/hcs.common.RetrieveDocumentCommon/DocId/092580/ContentSetId/100/SearchTerm/Zyban/SearchOption/BeginWith [subscription required] [Accessed November 22, 2008].
61. Delgado P.L., Brannan S.K., Mallinckrodt C.H., Tran P.V., McNamara R.K., Wang F., et al. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 66 (2005) 686-692
62. Micromedex healthcare series. Duloxetine hydrochloride. Available from: www.thomsonhc.com/hcs/librarian/ND_T/HCS/ND_PR/Main/CS/87F2E1/DUPLICATIONSHIELDSYNC/9F9844/ND_PG/PRIH/ND_B/HCS/SBK/1/ND_P/Main/PFPUI/n716h3m2IAX9Pj/PFActionId/hcs.common.RetrieveDocumentCommon/DocId/928196/ContentSetId/100/SearchTerm/Cymbalta/SearchOption/BeginWith [subscription required] [Accessed November 22, 2008].